Michael A Diefenbach
Hofstra University
19 Papers
83 Citations
Michael A Diefenbach is an academic researcher from Hofstra University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 8, co-authored 19 publications. Previous affiliations of Michael A Diefenbach include Smith Institute & The Feinstein Institute for Medical Research.
Chat about Author
Papers
Cost-effectiveness analysis of treatments for metastatic castration resistant prostate cancer
TL;DR: All treatment strategies greatly exceed a commonly assumed societal willingness-to-pay threshold of US$100,000 per LYS, and Enzalutamide + abiraterone + docetaxel exhibited the most favorable ICER among strategies without sipuleucel-T.
49
Use of Crowdsourcing for Cancer Clinical Trial Development
Amanda Leiter,Tomasz Sablinski,Michael A Diefenbach,Marc Foster,Alex Greenberg,John Holland,William Oh,Matthew D. Galsky +7 more
TL;DR: Evaluating the feasibility and utility of using an internet-based crowdsourcing platform to inform the design of a clinical trial exploring an antidiabetic drug, metformin, in prostate cancer found crowd-sourced input was collected leading to several major and minor modifications to the clinical trial protocol as originally designed.
42
Longitudinal dyadic associations of fear of cancer recurrence and the impact of treatment in prostate cancer patients and their spouses
TL;DR: This is the first study to have concurrently examined FCR longitudinally in prostate cancer patients and spouses, with patients’ and spouses’ FCR declined from pre- to post-treatment, with spouses experiencing greater FCR than patients over time.
20
Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT.
Michael A Diefenbach,Catherine Benedict,Catherine Benedict,Suzanne M. Miller,Annette L. Stanton,Mary E. Ropka,Kuang-Yi Wen,Linda Fleisher,Nihal Mohamed,Simon J. Hall +9 more
TL;DR: This nation-wide randomized controlled trial evaluated the impact of Healing Choices on reducing decisional conflict and distress in men diagnosed with early stage prostate cancer and found this interactive, comprehensive education and decision aid program may be most effective for a subset of prostate cancer patients in need of educational and decisional support.
20
Patient Factors and Hospital Outcomes Associated With Atypical Presentation in Hospitalized Older Adults With COVID-19 During the First Surge of the Pandemic.
Allison Marziliano,Allison Marziliano,Edith Burns,Edith Burns,Lakshpaul Chauhan,Yan Liu,Alex Makhnevich,Alex Makhnevich,Meng Zhang,Maria Torroella Carney,Maria Torroella Carney,Yasser Dbeis,Charlotta Lindvall,Michael Qiu,Michael A Diefenbach,Michael A Diefenbach,Liron Sinvani,Liron Sinvani +17 more
TL;DR: In this paper, the frequency of atypical presentation of COVID-19 among older adults was identified and compared with typical versus atypically presentations in OAs hospitalized with COVID19 during the first surge of the pandemic.
14